Stay updated with breaking news from Pratik Jain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A U.S. Food and Drug Administration advisory panel on Tuesday voted against a therapy based on the party drug MDMA for patients with post-traumatic stress disorder, marking a setback to the nascent... -June 04, 2024 at 05:39 pm EDT - MarketScreener
By Sriparna Roy and Pratik Jain (Reuters) - A panel of advisers to the U.S. Food and Drug Administration will meet on Tuesday to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder (PTSD). The meet...
By Pratik Jain and Christy Santhosh (Reuters) -Medtronic beat estimates for fourth-quarter revenue and profit on Thursday, helped by robust sales of its ...
(Reuters) - The U.S. Food and Drug Administration's panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder, Lykos Therapeutics said on Mo...
(Reuters) - Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday, driven by robust uptake for its cystic fibrosis treatments. Cystic fibrosis (CF) - an inherited disorder that causes severe damage to the lungs, diges...